Why are Neuren shares going parabolic?

Neuren shares have gone parabolic after it developed a profit-spinning drug to treat Rett syndrome, while Mesoblast has an August 2 date with the FDA. The company is up more than 700 per cent since 2021 after it developed a liquid drug to treat the childhood neurological disorder.

Who owns Neuren Pharmaceuticals?

Neuren Pharmaceuticals, 16 per cent owned by property magnate Lang Walker, ‘has the best risk-reward of the biotech world we have looked at since we first started pushing Mesoblast at 50¢ in 2009,’ Bell Potter said. Copyright © 2024.

Is Neuren a parabolic company?

Neuren has developed a drug that treats neurological disorders in children to improve hand movement and communication. Neuren shares have gone parabolic after it developed a profit-spinning drug to treat Rett syndrome, while Mesoblast has an August 2 date with the FDA.